Recurrence risk of node-negative and ER-positive early-stage breast cancer patients by combining recurrence score, pathologic, and clinical information: A meta-analysis approach

被引：0
|
作者：
Tang, G.
Cuzick, J.
Wale, C.
Costantino, J. P.
Crager, M.
Shak, S.
Wolmark, N.
Dowsett, M.
Forbes, J. F.
机构：
[1] Natl Surg Adjuvant Breast & Bowel Project, Pittsburgh, PA USA
[2] Univ London, London, England
[3] Genom Hlth, Redwood City, CA USA
[4] Natl Surg Adjuvant Breast & Bowel Project & Alleg, Pittsburgh, PA USA
[5] Royal Marsden Hosp, London SW3 6JJ, England
[6] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
509
引用
收藏
页数：1
相关论文
共 50 条
  • [31] NOMOGRAM PREDICTING RISK OF DISEASE RECURRENCE IN LYMPH NODE-NEGATIVE EARLY-STAGE CERVICAL CANCER PATIENTS FOLLOWING RADICAL HYSTERECTOMY
    Kong, T. W.
    Son, J. H.
    Paek, J.
    Chang, S. J.
    Ryu, H. S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 311 - 311
  • [32] Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score® Test in Node-Negative Early Breast Cancer
    Berdunov, Vladislav
    Millen, Steve
    Paramore, Andrew
    Griffin, Jane
    Reynia, Sarah
    Fryer, Nina
    Brown, Rebecca
    Longworth, Louise
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2022, 14 : 619 - 633
  • [33] Discrepancy in risk assessment of hormone receptor positive early-stage breast cancer patients using breast cancer index and recurrence score
    Jerevall, Piiha-Lotta
    Brock, Jane
    Palazzo, Juan
    Wieczorek, Tad
    Misialek, Michael
    Guidi, Anthony J.
    Wu, Yun
    Erlander, Mark G.
    Zhang, Yi
    Schnabel, Catherine A.
    Goss, Paul E.
    Horick, Nora
    Sgroi, Dennis C.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 173 (02) : 375 - 383
  • [34] Discrepancy in risk assessment of hormone receptor positive early-stage breast cancer patients using breast cancer index and recurrence score
    Piiha-Lotta Jerevall
    Jane Brock
    Juan Palazzo
    Tad Wieczorek
    Michael Misialek
    Anthony J. Guidi
    Yun Wu
    Mark G. Erlander
    Yi Zhang
    Catherine A. Schnabel
    Paul E. Goss
    Nora Horick
    Dennis C. Sgroi
    Breast Cancer Research and Treatment, 2019, 173 : 375 - 383
  • [35] Axillary management in patients with clinical node-negative early breast cancer and positive sentinel lymph node: a systematic review and meta-analysis
    Li, Changzai
    Zhang, Pan
    Lv, Jie
    Dong, Wei
    Hu, Baoshan
    Zhang, Jinji
    Zhu, Hongcheng
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [36] Utilizing the Oncotype DX Recurrence Score in the Adjuvant Treatment Management of Node-Positive, Early-Stage Breast Cancer Patients
    Nguyen, M. T.
    Chen, Z.
    D'Alfonso, T.
    Stessin, A.
    Nagar, H.
    Hayes, M.
    Shin, S. J.
    MODERN PATHOLOGY, 2013, 26 : 59A - 59A
  • [37] Utilizing the Oncotype DX Recurrence Score in the Adjuvant Treatment Management of Node-Positive, Early-Stage Breast Cancer Patients
    Nguyen, M. T.
    Chen, Z.
    D'Alfonso, T.
    Stessin, A.
    Nagar, H.
    Hayes, M.
    Shin, S. J.
    LABORATORY INVESTIGATION, 2013, 93 : 59A - 59A
  • [38] Prognostic value of the 21-gene recurrence score in ER-positive,HER2-negative, node-positive breast cancer was similar in node-negative diseases: a single-center study of 800 patients
    Jiayi Wu
    Weiqi Gao
    Xiaosong Chen
    Chunxiao Fei
    Lin Lin
    Weiguo Chen
    Ou Huang
    Siji Zhu
    Jianrong He
    Yafen Li
    Li Zhu
    Kunwei Shen
    Frontiers of Medicine, 2021, 15 (04) : 621 - 628
  • [39] Prognostic value of the 21-gene recurrence score in ER-positive, HER2-negative, node-positive breast cancer was similar in node-negative diseases: a single-center study of 800 patients
    Wu, Jiayi
    Gao, Weiqi
    Chen, Xiaosong
    Fei, Chunxiao
    Lin, Lin
    Chen, Weiguo
    Huang, Ou
    Zhu, Siji
    He, Jianrong
    Li, Yafen
    Zhu, Li
    Shen, Kunwei
    FRONTIERS OF MEDICINE, 2021, 15 (04) : 621 - 628
  • [40] Prognostic value of the 21-gene recurrence score in ER-positive, HER2-negative, node-positive breast cancer was similar in node-negative diseases: a single-center study of 800 patients
    Jiayi Wu
    Weiqi Gao
    Xiaosong Chen
    Chunxiao Fei
    Lin Lin
    Weiguo Chen
    Ou Huang
    Siji Zhu
    Jianrong He
    Yafen Li
    Li Zhu
    Kunwei Shen
    Frontiers of Medicine, 2021, 15 : 621 - 628
12345